Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT2 | P31751 | 8/20 | 0.45 |
| ▸ | GSK3B | P49841 | 2/20 | 0.45 |
| ▸ | KIT | P10721 | 1/20 | 0.45 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.39 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.39 |
| ▸ | AKT1 | P31749 | 3/20 | 0.36 |
| ▸ | SUV39H1 | O43463 | 2/20 | 0.34 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.34 |
| ▸ | SMYD3 | Q9H7B4 | 2/20 | 0.34 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.33 |
| ▸ | LCK | P06239 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.32 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28780956 | 0.86 | AKT2 (0.49) | AKT2GSK3BKITCHEK1CHEK2 | |
| SCHEMBL27747153 | 0.84 | HTR2C (0.40) | HTT | |
| SCHEMBL28780959 | 0.81 | JAK3 (0.33) | AKT2GSK3BKITAKT1HTT | |
| SCHEMBL27768080 | 0.79 | LMNA (0.39) | AKT2GSK3BCHEK1CHEK2LCK | |
| SCHEMBL27747155 | 0.78 | AKT2 (0.57) | AKT2GSK3BAKT1 | |
| SCHEMBL27768204 | 0.75 | VCP (0.41) | AKT1HTT | |
| SCHEMBL27768076 | 0.72 | PIK3CA (0.46) | ENPP1 | |
| SCHEMBL27768205 | 0.68 | RPS6KB1 (0.34) | AKT1LMNAHTT | |
| SCHEMBL1002593 | 0.67 | AKT2 (0.57) | AKT2GSK3BKITCHEK1CHEK2 | |
| SCHEMBL1003057 | 0.64 | AKT2 (0.64) | AKT2GSK3BKITCHEK1CHEK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101489559-B | Purine and deazapurine derivatives as pharmaceutical compounds | ASTEX THERAPEUTICS LTD | 2012-08-15 | — | — | CN | disclosed |
| CN-101489559-A | Purine and deazapurine derivatives as pharmaceutical compounds | ASTEX THERAPEUTICS LTD (GB) | 2009-07-22 | — | — | CN | disclosed |
| CN-101484173-A | Pharmaceutical combinations of pk inhibitors and other active agents | ASTEX THERAPEUTICS LTD (GB) | 2009-07-15 | — | — | CN | disclosed |